Trial intelligence / Profile preview

Metabolic Effects of Newer Antipsychotics in Older Patients

NCT00245206Phase 4Completed

Sponsor
Veterans Medical Research Foundation
Start
Aug 2005
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole, olanzapine, risperidone in schizophrenia, Alzheimer's disease (AD), Dementia, sponsored by Veterans Medical Research Foundation. Started Aug 2005; status: completed.

02

Drugs

aripiprazoleolanzapinerisperidone
03

Conditions

schizophreniaAlzheimer's disease (AD)Dementia

Beyond the preview

Go deeper on NCT00245206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00245206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call